Colonial Trust Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Colonial Trust Advisors's VRTX Position: Q2 2026 in Review
Colonial Trust Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 5.5% in Q2 2026, selling an estimated $5.76K and leaving 224 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #266.
Colonial Trust Advisors first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $122K in Q2 2024. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Colonial Trust Advisors held 224 shares of Vertex Pharmaceuticals worth $111K as of Q2 2026.
- Colonial Trust Advisors sold 13 Vertex Pharmaceuticals shares in Q2 2026, an estimated $5.76K.
- Vertex Pharmaceuticals made up 0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #266 holding.
- Colonial Trust Advisors first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
- Colonial Trust Advisors's Vertex Pharmaceuticals position peaked at $122K in Q2 2024.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.